Nuvo Pharmaceuticals Inc
F:23N
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Nuvo Pharmaceuticals Inc
F:23N
|
CA |
|
Vertiv Holdings Co
F:49V
|
US |
|
G
|
Gap Inc
DUS:GAP
|
US |
|
A
|
American International Group Inc
XMUN:AINN
|
US |
|
L
|
Logitech International SA
XHAM:LTEC
|
CH |
|
M
|
Matas A/S
F:1MTA
|
DK |
|
C
|
China Coal Energy Co Ltd
SWB:CVV
|
CN |
|
Newmark Group Inc
F:NMB
|
US |
|
H
|
Healthcare Realty Trust Inc
F:HR6
|
US |
|
NetEase Inc
F:4Y01
|
CN |
|
S
|
Secom Co Ltd
XMUN:XSC
|
JP |
|
Exxaro Resources Ltd
F:LCQ
|
ZA |
|
C
|
Citigroup Inc
F:TRVC
|
US |
|
U
|
United Parcel Service Inc
BMV:UPS
|
US |
|
C
|
Carrier Global Corp
F:4PN
|
US |
|
M
|
Mitsubishi Electric Corp
XMUN:MIE1
|
JP |
|
C
|
China Petroleum & Chemical Corp
DUS:CHU
|
CN |
|
Urban Edge Properties
NYSE:UE
|
US |
|
Canal+ SA
F:YA3
|
FR |
|
Fresenius SE & Co KGaA
MIL:FRE
|
DE |
|
J
|
Jacobs Solutions Inc
F:Z0Y
|
US |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
US |
|
I
|
IHS Markit Ltd
F:0M3
|
UK |
|
S
|
Smurfit Kappa Group PLC
XMUN:SK3
|
IE |
Dividends
Dividend Yield
Nuvo Pharmaceuticals Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Nuvo Pharmaceuticals Inc
23N have decreased by 0%.
Payout Ratio
Nuvo Pharmaceuticals Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 23N is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
23N Price
Nuvo Pharmaceuticals Inc
| Average Annual Return | 20.24% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -71% |
| Market Capitalization | 286.1B EUR |
| Shares Outstanding | 11 388 000 |
| Percentage of Shares Shorted |
N/A
|
23N Return Decomposition
Main factors of price return
Stock Splits
23N's latest stock split occurred on May 9, 2013
The company executed a 1-for-65 stock split, meaning that for every 65 shares held, investors received 1 new share.
Before the split, 23N traded at 0.007 per share. Afterward, the share price was about 1.85.
The adjusted shares began trading on May 9, 2013. This was the only stock split in 23N's history.
